{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:40:54Z","timestamp":1791945654539,"version":"4.3.4"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272231"],"award-info":[{"award-number":["82272231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472223"],"award-info":[{"award-number":["82472223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41380-026-03590-8","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:28:46Z","timestamp":1776094126000},"page":"5014-5030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pleiotropic modulation of the gut-brain-lung axis by ketamine and its enantiomers"],"prefix":"10.1038","volume":"31","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3138-681X","authenticated-orcid":false,"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6415-1604","authenticated-orcid":false,"given":"Shiying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-0851","authenticated-orcid":false,"given":"Jiancheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"3590_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1213\/ANE.0000000000006851","volume":"139","author":"G Mion","year":"2024","unstructured":"Mion G, Himmelseher S. Esketamine: less drowsiness, more analgesia. Anesth Analg. 2024;139:78\u201391. https:\/\/doi.org\/10.1213\/ANE.0000000000006851","journal-title":"Anesth Analg"},{"key":"3590_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/02698811241227026","volume":"38","author":"P Glue","year":"2024","unstructured":"Glue P, Neehoff S, Beaglehole B, Shadli S, McNaughton N, Hughes-Medlicott NJ. Ketamine for treatment-resistant major depressive disorder: double-blind active-controlled crossover study. J Psychopharmacol. 2024;38:162\u20137. https:\/\/doi.org\/10.1177\/02698811241227026","journal-title":"J Psychopharmacol"},{"key":"3590_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1192\/bjp.2023.79","volume":"223","author":"C Loo","year":"2023","unstructured":"Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, et al. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. Br J Psychiatry. 2023;223:533\u201341. https:\/\/doi.org\/10.1192\/bjp.2023.79","journal-title":"Br J Psychiatry"},{"key":"3590_CR4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/s41591-024-03063-x","volume":"30","author":"P Glue","year":"2024","unstructured":"Glue P, Loo C, Fam J, Lane H, Young AH, Surman P, et al. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nat Med. 2024;30:2004\u20139. https:\/\/doi.org\/10.1038\/s41591-024-03063-x","journal-title":"Nat Med"},{"key":"3590_CR5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41586-023-06624-1","volume":"622","author":"S Ma","year":"2023","unstructured":"Ma S, Chen M, Jiang Y, Xiang X, Wang S, Wu Z, et al. Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb. Nature. 2023;622:802\u20139. https:\/\/doi.org\/10.1038\/s41586-023-06624-1","journal-title":"Nature"},{"key":"3590_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jatmed.2024.07.001","volume":"3","author":"K Hashimoto","year":"2024","unstructured":"Hashimoto K, Zhao M, Zhu T, Wang X, Yang J. Ketamine and its two enantiomers in anesthesiology and psychiatry: a historical review and future directions. J Anesth Transl Med. 2024;3:65\u201375. https:\/\/doi.org\/10.1016\/j.jatmed.2024.07.001","journal-title":"J Anesth Transl Med"},{"key":"3590_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1177\/0271678X231167946","volume":"43","author":"B Xie","year":"2023","unstructured":"Xie B, Zhang Y, Han M, Wang M, Yu Y, Chen X, et al. Reversal of the detrimental effects of social isolation on ischemic cerebral injury and stroke-associated pneumonia by inhibiting small intestinal \u03b3\u03b4 T-cell migration into the brain and lung. J Cereb Blood Flow Metab. 2023;43:1267\u201384. https:\/\/doi.org\/10.1177\/0271678X231167946","journal-title":"J Cereb Blood Flow Metab"},{"key":"3590_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51209-9","volume":"15","author":"B Xie","year":"2024","unstructured":"Xie B, Wang M, Zhang X, Zhang Y, Qi H, Liu H, et al. Gut-derived memory \u03b3\u03b4 T17 cells exacerbate sepsis-induced acute lung injury in mice. Nat Commun. 2024;15:6737. https:\/\/doi.org\/10.1038\/s41467-024-51209-9","journal-title":"Nat Commun"},{"key":"3590_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1330021","volume":"15","author":"D Zhang","year":"2024","unstructured":"Zhang D, Lu J, Dong B, Fang M, Xiong X, Qin X, et al. Gut microbiota and its metabolic products in acute respiratory distress syndrome. Front Immunol. 2024;15:1330021. https:\/\/doi.org\/10.3389\/fimmu.2024.1330021","journal-title":"Front Immunol"},{"key":"3590_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pcn.12902","volume":"73","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective. Psychiatry Clin Neurosci. 2019;73:613\u201327. https:\/\/doi.org\/10.1111\/pcn.12902","journal-title":"Psychiatry Clin Neurosci"},{"key":"3590_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113935","volume":"177","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto K. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol. 2020;177:113935. https:\/\/doi.org\/10.1016\/j.bcp.2020.113935","journal-title":"Biochem Pharmacol"},{"key":"3590_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","volume":"27","author":"Y Wei","year":"2022","unstructured":"Wei Y, Chang L, Hashimoto K. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Mol Psychiatry. 2022;27:559\u201373. https:\/\/doi.org\/10.1038\/s41380-021-01121-1","journal-title":"Mol Psychiatry"},{"key":"3590_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","volume":"182","author":"L Chang","year":"2022","unstructured":"Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull. 2022;182:44\u201356. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.02.004","journal-title":"Brain Res Bull"},{"key":"3590_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","volume":"182","author":"Y Wei","year":"2022","unstructured":"Wei Y, Wang T, Liao L, Fan X, Chang L, Hashimoto K. Brain-spleen axis in health and diseases: a review and future perspective. Brain Res Bull. 2022;182:130\u201340. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.02.008","journal-title":"Brain Res Bull"},{"key":"3590_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03656-4","volume":"23","author":"M Han","year":"2025","unstructured":"Han M, Xie B, Yu Y, Xu D, Shi Y, Xu M, et al. Intestinal \u03b3\u03b4 T17-IL-17A signaling disrupts hippocampal mitophagy in stress-induced depression and is restored by arketamine. J Neuroinflammation. 2025;23:24. https:\/\/doi.org\/10.1186\/s12974-025-03656-4","journal-title":"J Neuroinflammation"},{"key":"3590_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.113","volume":"1","author":"RP Dickson","year":"2016","unstructured":"Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR, Standiford TJ, et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. 2016;1:16113. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.113","journal-title":"Nat Microbiol"},{"key":"3590_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/rccm.201907-1487OC","volume":"201","author":"RP Dickson","year":"2020","unstructured":"Dickson RP, Schultz MJ, van der Poll T, Schouten LR, Falkowski NR, Luth JE, et al. Lung microbiota predict clinical outcomes in critically ill patients. Am J Respir Crit Care Med. 2020;201:555\u201363. https:\/\/doi.org\/10.1164\/rccm.201907-1487OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3590_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4049\/jimmunol.2001304","volume":"207","author":"Q Pu","year":"2021","unstructured":"Pu Q, Lin P, Gao P, Wang Z, Guo K, Qin S, et al. Gut microbiota regulate gut-lung axis inflammatory responses by mediating ILC2 compartmental migration. J Immunol. 2021;207:257\u201367. https:\/\/doi.org\/10.4049\/jimmunol.2001304","journal-title":"J Immunol"},{"key":"3590_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.14336\/AD.2022.0104","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis. 2022;13:1106\u201326. https:\/\/doi.org\/10.14336\/AD.2022.0104","journal-title":"Aging Dis"},{"key":"3590_CR20","doi-asserted-by":"publisher","first-page":"863407","DOI":"10.3389\/fmicb.2022.863407","volume":"13","author":"C Li","year":"2022","unstructured":"Li C, Liang Y, Qiao Y. Messengers from the gut: gut microbiota-derived metabolites on host regulation. Front Microbiol. 2022;13:863407. https:\/\/doi.org\/10.3389\/fmicb.2022.863407","journal-title":"Front Microbiol"},{"key":"3590_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2310603","volume":"16","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Wang X, Chen J, Zhang Y, Hashimoto K, Yang J, et al. Repeated (S)-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota-brain axis. Gut microbes. 2024;16:2310603. https:\/\/doi.org\/10.1080\/19490976.2024.2310603","journal-title":"Gut microbes"},{"key":"3590_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105635","volume":"165","author":"X Wang","year":"2022","unstructured":"Wang X, Chang L, Wan X, Tan Y, Qu Y, Shan J, et al. (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis. Neurobiol Dis. 2022;165:105635. https:\/\/doi.org\/10.1016\/j.nbd.2022.105635","journal-title":"Neurobiol Dis"},{"key":"3590_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1124\/jpet.123.001823","volume":"388","author":"M J\u00f3\u017awiak-B\u0119benista","year":"2024","unstructured":"J\u00f3\u017awiak-B\u0119benista M, Soko\u0142owska P, Wiktorowska-Owczarek A, Kowalczyk E, Sienkiewicz M. Ketamine - a new antidepressant drug with anti-inflammatory properties. J Pharmacol Exp Ther. 2024;388:134\u201344. https:\/\/doi.org\/10.1124\/jpet.123.001823","journal-title":"J Pharmacol Exp Ther"},{"key":"3590_CR24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/02698811211026426","volume":"35","author":"E Kopra","year":"2021","unstructured":"Kopra E, Mondelli V, Pariante C, Nikkheslat N. Ketamine\u2019s effect on inflammation and kynurenine pathway in depression: a systematic review. J Psychopharmacol. 2021;35:934\u201345. https:\/\/doi.org\/10.1177\/02698811211026426","journal-title":"J Psychopharmacol"},{"key":"3590_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108431","volume":"246","author":"JN Johnston","year":"2023","unstructured":"Johnston JN, Henter ID, Zarate CAJ. The antidepressant actions of ketamine and its enantiomers. Pharmacol Ther. 2023;246:108431. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108431","journal-title":"Pharmacol Ther"},{"key":"3590_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/14740338.2021.1949454","volume":"21","author":"J Van Amsterdam","year":"2022","unstructured":"Van Amsterdam J, Van Den Brink W. Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. a systematic review and comparison study. Expert Opin Drug Saf. 2022;21:83\u201394. https:\/\/doi.org\/10.1080\/14740338.2021.1949454","journal-title":"Expert Opin Drug Saf"},{"key":"3590_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1176\/appi.ajp.21111086","volume":"179","author":"B O\u2019Brien","year":"2022","unstructured":"O\u2019Brien B, Wilkinson ST, Mathew SJ. An update on community ketamine practices. Am J Psychiatry. 2022;179:393\u20134. https:\/\/doi.org\/10.1176\/appi.ajp.21111086","journal-title":"Am J Psychiatry"},{"key":"3590_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23:801\u201311. https:\/\/doi.org\/10.1038\/mp.2017.255","journal-title":"Mol Psychiatry"},{"key":"3590_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.brainresbull.2006.06.005","volume":"70","author":"F Federico","year":"2006","unstructured":"Federico F, Leggio MG, Neri P, Mandolesi L, Petrosini L. NMDA receptor activity in learning spatial procedural strategies II. the influence of cerebellar lesions. Brain Res Bull. 2006;70:356\u201367. https:\/\/doi.org\/10.1016\/j.brainresbull.2006.06.005","journal-title":"Brain Res Bull"},{"key":"3590_CR30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55:1059\u201377. https:\/\/doi.org\/10.1007\/s40262-016-0383-6","journal-title":"Clin Pharmacokinet"},{"key":"3590_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109378","volume":"225","author":"S Lv","year":"2023","unstructured":"Lv S, Yao K, Zhang Y, Zhu S. NMDA receptors as therapeutic targets for depression treatment: evidence from clinical to basic research. Neuropharmacology. 2023;225:109378. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109378","journal-title":"Neuropharmacology"},{"key":"3590_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112631","volume":"390","author":"E Lavender","year":"2020","unstructured":"Lavender E, Hirasawa-Fujita M, Domino EF. Ketamine\u2019s dose related multiple mechanisms of actions: dissociative anesthetic to rapid antidepressant. Behav Brain Res. 2020;390:112631. https:\/\/doi.org\/10.1016\/j.bbr.2020.112631","journal-title":"Behav Brain Res"},{"key":"3590_CR33","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.4037\/ccn2020419","volume":"40","author":"K Brown","year":"2020","unstructured":"Brown K, Tucker C. Ketamine for acute pain management and sedation. Crit Care Nurse. 2020;40:e26\u2013e32. https:\/\/doi.org\/10.4037\/ccn2020419","journal-title":"Crit Care Nurse"},{"key":"3590_CR34","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291716000064","volume":"46","author":"T Kishimoto","year":"2016","unstructured":"Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, et al. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med. 2016;46:1459\u201372. https:\/\/doi.org\/10.1017\/S0033291716000064","journal-title":"Psychol Med"},{"key":"3590_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","volume":"172","author":"DJ Newport","year":"2015","unstructured":"Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB, et al. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015;172:950\u201366. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15040465","journal-title":"Am J Psychiatry"},{"key":"3590_CR36","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1038\/s41380-022-01587-7","volume":"27","author":"K Hashimoto","year":"2022","unstructured":"Hashimoto K. Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic? Mol Psychiatry. 2022;27:3116\u20138. https:\/\/doi.org\/10.1038\/s41380-022-01587-7","journal-title":"Mol Psychiatry"},{"key":"3590_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1126\/science.adx4559","volume":"388","author":"K Hashimoto","year":"2025","unstructured":"Hashimoto K. Extending ketamine\u2019s antidepressant effects. Science. 2025;388:589\u201390. https:\/\/doi.org\/10.1126\/science.adx4559","journal-title":"Science"},{"key":"3590_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00000542-199901000-00023","volume":"90","author":"K Hirota","year":"1999","unstructured":"Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology. 1999;90:174\u201382. https:\/\/doi.org\/10.1097\/00000542-199901000-00023","journal-title":"Anesthesiology"},{"key":"3590_CR39","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","volume":"26","author":"J Bonaventura","year":"2021","unstructured":"Bonaventura J, Lam S, Carlton M, Boehm MA, Gomez JL, Sol\u00eds O, et al. Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Mol Psychiatry. 2021;26:6704\u201322. https:\/\/doi.org\/10.1038\/s41380-021-01093-2","journal-title":"Mol Psychiatry"},{"key":"3590_CR40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","volume":"175","author":"NR Williams","year":"2018","unstructured":"Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, et al. Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry. 2018;175:1205\u201315. https:\/\/doi.org\/10.1176\/appi.ajp.2018.18020138","journal-title":"Am J Psychiatry"},{"key":"3590_CR41","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1038\/s41591-025-03800-w","volume":"31","author":"LA Jelen","year":"2025","unstructured":"Jelen LA, Lythgoe DJ, Stone JM, Young AH, Mehta MA. Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study. Nat Med. 2025;31:2958\u201366. https:\/\/doi.org\/10.1038\/s41591-025-03800-w","journal-title":"Nat Med"},{"key":"3590_CR42","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.biopsych.2018.11.006","volume":"85","author":"K Zhang","year":"2019","unstructured":"Zhang K, Hashimoto K. Lack of opioid system in the antidepressant actions of ketamine. Biol psychiatry. 2019;85:e25\u2013e27. https:\/\/doi.org\/10.1016\/j.biopsych.2018.11.006","journal-title":"Biol psychiatry"},{"key":"3590_CR43","doi-asserted-by":"publisher","first-page":"f56","DOI":"10.1093\/ijnp\/pyaf056","volume":"28","author":"G Yoon","year":"2025","unstructured":"Yoon G, Pittman B, Ralevski E, Petrakis IL, Krystal JH. Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial. Int J Neuropsychopharmacol. 2025;28:f56. https:\/\/doi.org\/10.1093\/ijnp\/pyaf056","journal-title":"Int J Neuropsychopharmacol"},{"key":"3590_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamapsychiatry.2018.3990","volume":"76","author":"G Yoon","year":"2019","unstructured":"Yoon G, Petrakis IL, Krystal JH. Association of combined naltrexone and ketamine with depressive symptoms in a case series of patients with depression and alcohol use disorder. JAMA psychiatry. 2019;76:337\u20138. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3990","journal-title":"JAMA psychiatry"},{"key":"3590_CR45","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1073\/pnas.1916570117","volume":"117","author":"ME Klein","year":"2020","unstructured":"Klein ME, Chandra J, Sheriff S, Malinow R. Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents. Proc Natl Acad Sci USA. 2020;117:2656\u201362. https:\/\/doi.org\/10.1073\/pnas.1916570117","journal-title":"Proc Natl Acad Sci USA"},{"key":"3590_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02796-0","volume":"14","author":"C Jiang","year":"2024","unstructured":"Jiang C, DiLeone RJ, Pittenger C, Duman RS. The endogenous opioid system in the medial prefrontal cortex mediates ketamine\u2019s antidepressant-like actions. Transl Psychiatry. 2024;14:90. https:\/\/doi.org\/10.1038\/s41398-024-02796-0","journal-title":"Transl Psychiatry"},{"key":"3590_CR47","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1073\/pnas.2001264117","volume":"117","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto K. Are NMDA and opioid receptors involved in the antidepressant actions of ketamine? Proc Natl Acad Sci USA. 2020;117:11200\u20131. https:\/\/doi.org\/10.1073\/pnas.2001264117","journal-title":"Proc Natl Acad Sci USA"},{"key":"3590_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","volume":"182","author":"MR Levinstein","year":"2025","unstructured":"Levinstein MR, Budinich RC, Bonaventura J, Schatzberg AF, Zarate CAJ, Michaelides M. Redefining ketamine pharmacology for antidepressant action: synergistic NMDA and opioid receptor interactions? Am J Psychiatry. 2025;182:247\u201358. https:\/\/doi.org\/10.1176\/appi.ajp.20240378","journal-title":"Am J Psychiatry"},{"key":"3590_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109313","volume":"223","author":"Y Ago","year":"2023","unstructured":"Ago Y, Yokoyama R, Asano S, Hashimoto H. Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites. Neuropharmacology. 2023;223:109313. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109313","journal-title":"Neuropharmacology"},{"key":"3590_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109325","volume":"223","author":"T Kato","year":"2023","unstructured":"Kato T. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants. Neuropharmacology. 2023;223:109325. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109325","journal-title":"Neuropharmacology"},{"key":"3590_CR51","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/s41380-023-02288-5","volume":"29","author":"C Huang","year":"2024","unstructured":"Huang C, Wu Z, Wang D, Qu Y, Zhang J, Jiang R, et al. Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine. Mol Psychiatry. 2024;29:1741\u201353. https:\/\/doi.org\/10.1038\/s41380-023-02288-5","journal-title":"Mol Psychiatry"},{"key":"3590_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109305","volume":"222","author":"K Zhang","year":"2023","unstructured":"Zhang K, Yao Y, Hashimoto K. Ketamine and its metabolites: potential as novel treatments for depression. Neuropharmacology. 2023;222:109305. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109305","journal-title":"Neuropharmacology"},{"key":"3590_CR53","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","volume":"77","author":"J Yang","year":"2015","unstructured":"Yang J, Wang N, Yang C, Shi J, Yu H, Hashimoto K. Serum interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry. 2015;77:e19\u2013e20. https:\/\/doi.org\/10.1016\/j.biopsych.2014.06.021","journal-title":"Biol Psychiatry"},{"key":"3590_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100383","volume":"18","author":"N Nikkheslat","year":"2021","unstructured":"Nikkheslat N. Targeting inflammation in depression: ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain Behav Immun. 2021;18:100383. https:\/\/doi.org\/10.1016\/j.bbih.2021.100383","journal-title":"Brain Behav Immun"},{"key":"3590_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03590-3","volume":"7","author":"Z Xie","year":"2017","unstructured":"Xie Z, Wang X, Xu N, Wang J, Pan W, Tang X, et al. Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine. Sci Rep. 2017;7:3124. https:\/\/doi.org\/10.1038\/s41598-017-03590-3","journal-title":"Sci Rep"},{"key":"3590_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115918","volume":"218","author":"P Soko\u0142owska","year":"2023","unstructured":"Soko\u0142owska P, Seweryn Karbownik M, J\u00f3\u017awiak-B\u0119benista M, Dobielska M, Kowalczyk E, Wiktorowska-Owczarek A. Antidepressant mechanisms of ketamine\u2019s action: NF-\u03baB in the spotlight. Biochem Pharmacol. 2023;218:115918. https:\/\/doi.org\/10.1016\/j.bcp.2023.115918","journal-title":"Biochem Pharmacol"},{"key":"3590_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109272","volume":"220","author":"H Hua","year":"2022","unstructured":"Hua H, Huang C, Liu H, Xu X, Xu X, Wu Z, et al. Depression and antidepressant effects of ketamine and its metabolites: the pivotal role of gut microbiota. Neuropharmacology. 2022;220:109272. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109272","journal-title":"Neuropharmacology"},{"key":"3590_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang J, Ren Q, Yao W, Ma M, et al. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry. 2015;5:e632. https:\/\/doi.org\/10.1038\/tp.2015.136","journal-title":"Transl Psychiatry"},{"key":"3590_CR59","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ijnp\/pyz041","volume":"22","author":"Y Ago","year":"2019","unstructured":"Ago Y, Tanabe W, Higuchi M, Tsukada S, Tanaka T, Yamaguchi T, et al. (R)-ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism. Int J Neuropsychopharmacol. 2019;22:665\u201374. https:\/\/doi.org\/10.1093\/ijnp\/pyz041","journal-title":"Int J Neuropsychopharmacol"},{"key":"3590_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbi.2023.09.026","volume":"115","author":"X Zhang","year":"2024","unstructured":"Zhang X, He T, Wu Z, Wang Y, Liu H, Zhang B, et al. The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine. Brain Behav Immun. 2024;115:64\u201379. https:\/\/doi.org\/10.1016\/j.bbi.2023.09.026","journal-title":"Brain Behav Immun"},{"key":"3590_CR61","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41380-024-02419-6","volume":"29","author":"R Yokoyama","year":"2024","unstructured":"Yokoyama R, Ago Y, Igarashi H, Higuchi M, Tanuma M, Shimazaki Y, et al. (R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice. Mol Psychiatry. 2024;29:1406\u201316. https:\/\/doi.org\/10.1038\/s41380-024-02419-6","journal-title":"Mol Psychiatry"},{"key":"3590_CR62","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00406-020-01110-5","volume":"271","author":"GC Leal","year":"2021","unstructured":"Leal GC, Bandeira ID, Correia-Melo FS, Telles M, Mello RP, Vieira F, et al. Intravenous arketamine for treatment-resistant depression: open-label pilot study. Eur Arch Psychiatry Clin Neurosci. 2021;271:577\u201382. https:\/\/doi.org\/10.1007\/s00406-020-01110-5","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3590_CR63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jpsychires.2023.06.028","volume":"164","author":"ID Bandeira","year":"2023","unstructured":"Bandeira ID, Leal GC, Correia-Melo FS, Souza-Marques B, Silva SS, Lins-Silva DH, et al. Arketamine for bipolar depression: open-label, dose-escalation, pilot study. J Psychiatr Res. 2023;164:229\u201334. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.06.028","journal-title":"J Psychiatr Res"},{"key":"3590_CR64","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00406-024-01945-2","volume":"275","author":"GC Leal","year":"2025","unstructured":"Leal GC, Lima-Ara\u00fajo I, Roiter DG, Caliman-Fontes AT, Mello RP, Kapczinski F, et al. Arketamine: a scoping review of its use in humans. Eur Arch Psychiatry Clin Neurosci. 2025;275:1317\u201332. https:\/\/doi.org\/10.1007\/s00406-024-01945-2","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3590_CR65","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.brainresbull.2021.10.013","volume":"177","author":"X Wang","year":"2021","unstructured":"Wang X, Chang L, Tan Y, Qu Y, Shan J, Hashimoto K. (R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice. Brain Res Bull. 2021;177:316\u201323. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.10.013","journal-title":"Brain Res Bull"},{"key":"3590_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173954","volume":"897","author":"Y Fujita","year":"2021","unstructured":"Fujita Y, Hashimoto Y, Hashimoto H, Chang L, Hashimoto K. Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling. Eur J Pharmacol. 2021;897:173954. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173954","journal-title":"Eur J Pharmacol"},{"key":"3590_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172904","volume":"191","author":"Z Xiong","year":"2020","unstructured":"Xiong Z, Chang L, Qu Y, Pu Y, Wang S, Fujita Y, et al. Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine. Pharmacol Biochem Behav. 2020;191:172904. https:\/\/doi.org\/10.1016\/j.pbb.2020.172904","journal-title":"Pharmacol Biochem Behav"},{"key":"3590_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119882","volume":"284","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ma L, Hashimoto Y, Wan X, Shan J, Qu Y, et al. (R)-Ketamine ameliorates lethal inflammatory responses and multi-organ injury in mice induced by cecum ligation and puncture. Life Sci. 2021;284:119882. https:\/\/doi.org\/10.1016\/j.lfs.2021.119882","journal-title":"Life Sci"},{"key":"3590_CR69","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00213-021-05889-6","volume":"238","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ma L, Wan X, Shan J, Qu Y, Hashimoto K. (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation. Psychopharmacology. 2021;238:2743\u201353. https:\/\/doi.org\/10.1007\/s00213-021-05889-6","journal-title":"Psychopharmacology"},{"key":"3590_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0733-x","volume":"10","author":"K Zhang","year":"2020","unstructured":"Zhang K, Yang C, Chang L, Sakamoto A, Suzuki T, Fujita Y, et al. Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21. Transl Psychiatry. 2020;10:32. https:\/\/doi.org\/10.1038\/s41398-020-0733-x","journal-title":"Transl Psychiatry"},{"key":"3590_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16060-7","volume":"7","author":"Y Qu","year":"2017","unstructured":"Qu Y, Yang C, Ren Q, Ma M, Dong C, Hashimoto K. Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model. Sci Rep. 2017;7:15725. https:\/\/doi.org\/10.1038\/s41598-017-16060-7","journal-title":"Sci Rep"},{"key":"3590_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0031-4","volume":"7","author":"C Yang","year":"2017","unstructured":"Yang C, Qu Y, Fujita Y, Ren Q, Ma M, Dong C, et al. Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. Transl Psychiatry. 2017;7:1294. https:\/\/doi.org\/10.1038\/s41398-017-0031-4","journal-title":"Transl Psychiatry"},{"key":"3590_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.868103","volume":"13","author":"DS Mathai","year":"2022","unstructured":"Mathai DS, Mora V, Garcia-Romeu A. Toward synergies of ketamine and psychotherapy. Front Psychol. 2022;13:868103. https:\/\/doi.org\/10.3389\/fpsyg.2022.868103","journal-title":"Front Psychol"},{"key":"3590_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jad.2023.02.151","volume":"330","author":"GC Leal","year":"2023","unstructured":"Leal GC, Souza-Marques B, Mello RP, Bandeira ID, Caliman-Fontes AT, Carneiro BA, et al. Arketamine as adjunctive therapy for treatment-resistant depression: a placebo-controlled pilot study. J Affect Disord. 2023;330:7\u201315. https:\/\/doi.org\/10.1016\/j.jad.2023.02.151","journal-title":"J Affect Disord"},{"key":"3590_CR75","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","volume":"27","author":"W Yao","year":"2022","unstructured":"Yao W, Cao Q, Luo S, He L, Yang C, Chen J, et al. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine. Mol Psychiatry. 2022;27:1618\u201329. https:\/\/doi.org\/10.1038\/s41380-021-01377-7","journal-title":"Mol Psychiatry"},{"key":"3590_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","volume":"83","author":"C Yang","year":"2018","unstructured":"Yang C, Ren Q, Qu Y, Zhang J, Ma M, Dong C, et al. Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model. Bio psychiatry. 2018;83:18\u201328. https:\/\/doi.org\/10.1016\/j.biopsych.2017.05.016","journal-title":"Bio psychiatry"},{"key":"3590_CR77","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/ijnp\/pyad050","volume":"26","author":"S Koncz","year":"2023","unstructured":"Koncz S, Papp N, Pothorszki D, Bagdy G. (S)-ketamine but not (R)-ketamine shows acute effects on depression-like behavior and sleep-wake architecture in rats. Int J Neuropsychopharmacol. 2023;26:618\u201326. https:\/\/doi.org\/10.1093\/ijnp\/pyad050","journal-title":"Int J Neuropsychopharmacol"},{"key":"3590_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1108-y","volume":"21","author":"A Lengvenyte","year":"2019","unstructured":"Lengvenyte A, Oli\u00e9 E, Courtet P. Suicide Has Many Faces, So Does Ketamine: a narrative review on ketamine\u2019s antisuicidal actions. Curr Psychiatry Rep. 2019;21:132. https:\/\/doi.org\/10.1007\/s11920-019-1108-y","journal-title":"Curr Psychiatry Rep"},{"key":"3590_CR79","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.biopsych.2018.05.007","volume":"84","author":"C Yang","year":"2018","unstructured":"Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, et al. AMPA receptor activation-independent antidepressant actions of ketamine metabolite (S)-norketamine. Biol psychiatry. 2018;84:591\u2013600. https:\/\/doi.org\/10.1016\/j.biopsych.2018.05.007","journal-title":"Biol psychiatry"},{"key":"3590_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172876","volume":"191","author":"R Yokoyama","year":"2020","unstructured":"Yokoyama R, Higuchi M, Tanabe W, Tsukada S, Naito M, Yamaguchi T, et al. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression. Pharmacol Biochem Behav. 2020;191:172876. https:\/\/doi.org\/10.1016\/j.pbb.2020.172876","journal-title":"Pharmacol Biochem Behav"},{"key":"3590_CR81","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jphs.2023.12.005","volume":"154","author":"R Yokoyama","year":"2024","unstructured":"Yokoyama R, Higuchi M, Tanabe W, Tsukada S, Igarashi H, Seiriki K, et al. Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice. J Pharmacol Sci. 2024;154:72\u201376. https:\/\/doi.org\/10.1016\/j.jphs.2023.12.005","journal-title":"J Pharmacol Sci"},{"key":"3590_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173226","volume":"207","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jiang R, Wu Z, Zhou L, Xu J, Huang C, et al. Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression. Pharmacol Biochem Behav. 2021;207:173226. https:\/\/doi.org\/10.1016\/j.pbb.2021.173226","journal-title":"Pharmacol Biochem Behav"},{"key":"3590_CR83","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00406-018-0922-2","volume":"269","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K, Yang C. Is (S)-norketamine an alternative antidepressant for esketamine? Eur Arch Psychiatry Clin Neurosci. 2019;269:867\u20138. https:\/\/doi.org\/10.1007\/s00406-018-0922-2","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3590_CR84","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1038\/s41380-025-03085-y","volume":"30","author":"X Feng","year":"2025","unstructured":"Feng X, Jia M, Cai M, Zhu T, Hashimoto K, Yang J. Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research. Mol Psychiatry. 2025;30:4881\u201398. https:\/\/doi.org\/10.1038\/s41380-025-03085-y","journal-title":"Mol Psychiatry"},{"key":"3590_CR85","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0014-4886(86)90088-9","volume":"92","author":"W Wyrwicka","year":"1986","unstructured":"Wyrwicka W. Quinine tolerance during self-stimulation in cats. Exp Neurol. 1986;92:369\u201376. https:\/\/doi.org\/10.1016\/0014-4886(86)90088-9","journal-title":"Exp Neurol"},{"key":"3590_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62181-3","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang Y, Yu Y, Wang X, Zhen Z, Yuan Y, et al. Small intestinal \u03b3\u03b4 T17 cells promote SAE through STING\/C1q-induced microglial synaptic pruning in male mice. Nat Commun. 2025;16:6779. https:\/\/doi.org\/10.1038\/s41467-025-62181-3","journal-title":"Nat Commun"},{"key":"3590_CR87","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1007\/s00018-021-03812-y","volume":"78","author":"AM Holland","year":"2021","unstructured":"Holland AM, Bon-Frauches AC, Keszthelyi D, Melotte V, Boesmans W. The enteric nervous system in gastrointestinal disease etiology. Cell Mol Life Sci. 2021;78:4713\u201333. https:\/\/doi.org\/10.1007\/s00018-021-03812-y","journal-title":"Cell Mol Life Sci"},{"key":"3590_CR88","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00018.2022","volume":"103","author":"KA Sharkey","year":"2023","unstructured":"Sharkey KA, Mawe GM. The enteric nervous system. Physiol Rev. 2023;103:1487\u2013564. https:\/\/doi.org\/10.1152\/physrev.00018.2022","journal-title":"Physiol Rev"},{"key":"3590_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102183","volume":"77","author":"F Progatzky","year":"2022","unstructured":"Progatzky F, Pachnis V. The role of enteric glia in intestinal immunity. Curr Opin Immunol. 2022;77:102183. https:\/\/doi.org\/10.1016\/j.coi.2022.102183","journal-title":"Curr Opin Immunol"},{"key":"3590_CR90","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2220\/biomedres.41.199","volume":"41","author":"A Kuwahara","year":"2020","unstructured":"Kuwahara A, Matsuda K, Kuwahara Y, Asano S, Inui T, Marunaka Y. Microbiota-gut-brain axis: enteroendocrine cells and the enteric nervous system form an interface between the microbiota and the central nervous system. Biomed Res. 2020;41:199\u2013216. https:\/\/doi.org\/10.2220\/biomedres.41.199","journal-title":"Biomed Res"},{"key":"3590_CR91","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2024.11.023","volume":"124","author":"L Ma","year":"2025","unstructured":"Ma L, Wang H, Hashimoto K. The vagus nerve: an old but new player in brain-body communication. Brain Behav Immun. 2025;124:28\u201339. https:\/\/doi.org\/10.1016\/j.bbi.2024.11.023","journal-title":"Brain Behav Immun"},{"key":"3590_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105951","volume":"176","author":"X Wang","year":"2023","unstructured":"Wang X, Eguchi A, Yang Y, Chang L, Wan X, Shan J, et al. Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain. Neurobiol Dis. 2023;176:105951. https:\/\/doi.org\/10.1016\/j.nbd.2022.105951","journal-title":"Neurobiol Dis"},{"key":"3590_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpsychires.2023.09.003","volume":"166","author":"C Yue","year":"2023","unstructured":"Yue C, Luan W, Gu H, Qiu D, Ding X, Liu P, et al. The role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in chronic inflammatory pain and comorbid spatial working memory impairment in complete Freund\u2019s adjuvant mice. J Psychiatr Res. 2023;166:61\u201373. https:\/\/doi.org\/10.1016\/j.jpsychires.2023.09.003","journal-title":"J Psychiatr Res"},{"key":"3590_CR94","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bbi.2024.10.026","volume":"123","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liao J, Jan M, Wang M, Su H, Tsai W, et al. Prophylactic use of probiotics as an adjunctive treatment for ischemic stroke via the gut-spleen-brain axis. Brain Behav Immun. 2025;123:784\u201398. https:\/\/doi.org\/10.1016\/j.bbi.2024.10.026","journal-title":"Brain Behav Immun"},{"key":"3590_CR95","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jad.2024.06.091","volume":"362","author":"Y Yang","year":"2024","unstructured":"Yang Y, Eguchi A, Mori C, Hashimoto K. Splenic nerve denervation attenuates depression-like behaviors in Chrna7 knock-out mice via the spleen-gut-brain axis. J Affect Disord. 2024;362:114\u201325. https:\/\/doi.org\/10.1016\/j.jad.2024.06.091","journal-title":"J Affect Disord"},{"key":"3590_CR96","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355\u20139. https:\/\/doi.org\/10.1126\/science.1124234","journal-title":"Science"},{"key":"3590_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1138971","volume":"14","author":"T Ogino","year":"2023","unstructured":"Ogino T, Takeda K. Immunoregulation by antigen-presenting cells in human intestinal lamina propria. Front Immunol. 2023;14:1138971. https:\/\/doi.org\/10.3389\/fimmu.2023.1138971","journal-title":"Front Immunol"},{"key":"3590_CR98","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10228","volume":"475","author":"E Esplugues","year":"2011","unstructured":"Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY, et al. Control of TH17 cells occurs in the small intestine. Nature. 2011;475:514\u20138. https:\/\/doi.org\/10.1038\/nature10228","journal-title":"Nature"},{"key":"3590_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670500","volume":"12","author":"S Westfall","year":"2021","unstructured":"Westfall S, Caracci F, Estill M, Frolinger T, Shen L, Pasinetti GM. Chronic stress-induced depression and anxiety priming modulated by gut-brain-axis immunity. Front Immunol. 2021;12:670500. https:\/\/doi.org\/10.3389\/fimmu.2021.670500","journal-title":"Front Immunol"},{"key":"3590_CR100","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","volume":"40","author":"P Wu","year":"2014","unstructured":"Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, et al. \u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity. 2014;40:785\u2013800. https:\/\/doi.org\/10.1016\/j.immuni.2014.03.013","journal-title":"Immunity"},{"key":"3590_CR101","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbi.2021.05.008","volume":"96","author":"D Brea","year":"2021","unstructured":"Brea D, Poon C, Benakis C, Lubitz G, Murphy M, Iadecola C, et al. Stroke affects intestinal immune cell trafficking to the central nervous system. Brain Behav Immun. 2021;96:295\u2013302. https:\/\/doi.org\/10.1016\/j.bbi.2021.05.008","journal-title":"Brain Behav Immun"},{"key":"3590_CR102","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1161\/STROKEAHA.117.016753","volume":"48","author":"P Arunachalam","year":"2017","unstructured":"Arunachalam P, Ludewig P, Melich P, Arumugam TV, Gerloff C, Prinz I, et al. CCR6 (CC chemokine receptor 6) is essential for the migration of detrimental natural interleukin-17-producing \u03b3\u03b4 T cells in stroke. Stroke. 2017;48:1957\u201365. https:\/\/doi.org\/10.1161\/STROKEAHA.117.016753","journal-title":"Stroke"},{"key":"3590_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2024.173906","volume":"245","author":"G Liu","year":"2024","unstructured":"Liu G, Ma L, Sakamoto A, Fujimura L, Xu D, Zhao M, et al. Splenic \u03b3\u03b4 T cells mediate antidepressant and prophylactic actions of arketamine in lipopolysaccharide-induced depression in mice. Pharmacol Biochem Behav. 2024;245:173906. https:\/\/doi.org\/10.1016\/j.pbb.2024.173906","journal-title":"Pharmacol Biochem Behav"},{"key":"3590_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117094","volume":"240","author":"L Ma","year":"2025","unstructured":"Ma L, Zeng W, Song K, Xie T, Han S, Li Y, et al. Splenic \u03b3\u03b4 T cells are required for vagotomy-mediated protection against LPS-induced depression- and anxiety-like behaviors through the spleen-brain axis. Biochem Pharmacol. 2025;240:117094. https:\/\/doi.org\/10.1016\/j.bcp.2025.117094","journal-title":"Biochem Pharmacol"},{"key":"3590_CR105","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-023-02287-6","volume":"28","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K. Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions. Mol Psychiatry. 2023;28:3625\u201337. https:\/\/doi.org\/10.1038\/s41380-023-02287-6","journal-title":"Mol Psychiatry"},{"key":"3590_CR106","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3389\/fimmu.2019.02441","volume":"10","author":"S Negi","year":"2019","unstructured":"Negi S, Das DK, Pahari S, Nadeem S, Agrewala JN. Potential role of gut microbiota in induction and regulation of innate immune memory. Front Immunol. 2019;10:2441. https:\/\/doi.org\/10.3389\/fimmu.2019.02441","journal-title":"Front Immunol"},{"key":"3590_CR107","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17:219\u201332. https:\/\/doi.org\/10.1038\/nri.2017.7","journal-title":"Nat Rev Immunol"},{"key":"3590_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1059042","volume":"13","author":"Y Gui","year":"2022","unstructured":"Gui Y, Cheng H, Zhou J, Xu H, Han J, Zhang D. Development and function of natural TCR+ CD8\u03b1\u03b1+ intraepithelial lymphocytes. Front Immunol. 2022;13:1059042. https:\/\/doi.org\/10.3389\/fimmu.2022.1059042","journal-title":"Front Immunol"},{"key":"3590_CR109","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3934\/Neuroscience.2024004","volume":"11","author":"T Awe","year":"2024","unstructured":"Awe T, Fasawe A, Sawe C, Ogunware A, Jamiu AT, Allen M. The modulatory role of gut microbiota on host behavior: exploring the interaction between the brain-gut axis and the neuroendocrine system. AIMS Neurosci. 2024;11:49\u201362. https:\/\/doi.org\/10.3934\/Neuroscience.2024004","journal-title":"AIMS Neurosci"},{"key":"3590_CR110","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/acschemneuro.3c00127","volume":"14","author":"JM Sasso","year":"2023","unstructured":"Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, et al. Gut microbiome-brain alliance: a landscape view into mental and gastrointestinal health and disorders. ACS Chem Neurosci. 2023;14:1717\u201363. https:\/\/doi.org\/10.1021\/acschemneuro.3c00127","journal-title":"ACS Chem Neurosci"},{"key":"3590_CR111","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/15548627.2022.2102309","volume":"19","author":"F Li","year":"2023","unstructured":"Li F, Wang Y, Zheng K. Microglial mitophagy integrates the microbiota-gut-brain axis to restrain neuroinflammation during neurotropic herpesvirus infection. Autophagy. 2023;19:734\u20136. https:\/\/doi.org\/10.1080\/15548627.2022.2102309","journal-title":"Autophagy"},{"key":"3590_CR112","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","volume":"57","author":"S Liu","year":"2020","unstructured":"Liu S, Gao J, Zhu M, Liu K, Zhang H. Gut microbiota and dysbiosis in alzheimer\u2019s disease: implications for pathogenesis and treatment. Mol Neurobiol. 2020;57:5026\u201343. https:\/\/doi.org\/10.1007\/s12035-020-02073-3","journal-title":"Mol Neurobiol"},{"key":"3590_CR113","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1570159X18666200606233050","volume":"19","author":"G Kaur","year":"2021","unstructured":"Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, et al. Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated parkinson\u2019s disease. Curr Neuropharmacol. 2021;19:233\u201347. https:\/\/doi.org\/10.2174\/1570159X18666200606233050","journal-title":"Curr Neuropharmacol"},{"key":"3590_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70417","volume":"21","author":"JW Kang","year":"2025","unstructured":"Kang JW, Khatib LA, Heston MB, Dilmore AH, Labus JS, Deming Y, et al. Gut microbiome compositional and functional features associate with alzheimer\u2019s disease pathology. Alzheimers Dement. 2025;21:e70417. https:\/\/doi.org\/10.1002\/alz.70417","journal-title":"Alzheimers Dement"},{"key":"3590_CR115","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jointm.2023.01.001","volume":"3","author":"L Le Guennec","year":"2023","unstructured":"Le Guennec L, Weiss N. Blood-brain barrier dysfunction in intensive care unit. J Intensive Med. 2023;3:303\u201312. https:\/\/doi.org\/10.1016\/j.jointm.2023.01.001","journal-title":"J Intensive Med"},{"key":"3590_CR116","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5958\/2394-2061.2022.00016.7","volume":"13","author":"S Jaiswal","year":"2022","unstructured":"Jaiswal S, Bag A, Bhandari SS. Gut microbiota and psychiatric disorders. Open J Psychiatry Allied Sci. 2022;13:90\u201393. https:\/\/doi.org\/10.5958\/2394-2061.2022.00016.7","journal-title":"Open J Psychiatry Allied Sci"},{"key":"3590_CR117","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11682-021-00513-9","volume":"16","author":"X Huang","year":"2022","unstructured":"Huang X, Li L, Ling Z, Gao L, Chen H, Duan X. Gut microbiome diversity mediates the association between right dorsolateral prefrontal cortex and anxiety level. Brain Imaging Behav. 2022;16:397\u2013405. https:\/\/doi.org\/10.1007\/s11682-021-00513-9","journal-title":"Brain Imaging Behav"},{"key":"3590_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1324018","volume":"15","author":"TA Hediyal","year":"2024","unstructured":"Hediyal TA, Vichitra C, Anand N, Bhaskaran M, Essa SM, Kumar P, et al. Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update. Front Immunol. 2024;15:1324018. https:\/\/doi.org\/10.3389\/fimmu.2024.1324018","journal-title":"Front Immunol"},{"key":"3590_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117207","volume":"178","author":"S Lu","year":"2024","unstructured":"Lu S, Zhao Q, Guan Y, Sun Z, Li W, Guo S, et al. The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: a systematic review. Biomed Pharmacother. 2024;178:117207. https:\/\/doi.org\/10.1016\/j.biopha.2024.117207","journal-title":"Biomed Pharmacother"},{"key":"3590_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1224092","volume":"14","author":"W Sheng","year":"2023","unstructured":"Sheng W, Ji G, Zhang L. Immunomodulatory effects of inulin and its intestinal metabolites. Front Immunol. 2023;14:1224092. https:\/\/doi.org\/10.3389\/fimmu.2023.1224092","journal-title":"Front Immunol"},{"key":"3590_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian Y, Zhang Y, Li Y, Gu L, Sun H, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21:212. https:\/\/doi.org\/10.1186\/s12964-023-01219-9","journal-title":"Cell Commun Signal"},{"key":"3590_CR122","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2022.02.007","volume":"102","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Fan Q, Hou Y, Zhang X, Yin Z, Cai X, et al. Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling. Brain Behav Immun. 2022;102:11\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2022.02.007","journal-title":"Brain Behav Immun"},{"key":"3590_CR123","doi-asserted-by":"publisher","first-page":"480","DOI":"10.14336\/AD.2023.0727","volume":"15","author":"W Deng","year":"2024","unstructured":"Deng W, Yi P, Xiong Y, Ying J, Lin Y, Dong Y, et al. Gut metabolites acting on the gut-brain axis: regulating the functional state of microglia. Aging Dis. 2024;15:480\u2013502. https:\/\/doi.org\/10.14336\/AD.2023.0727","journal-title":"Aging Dis"},{"key":"3590_CR124","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nm.4068","volume":"22","author":"C Benakis","year":"2016","unstructured":"Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal \u03b3\u03b4 T cells. Nat Med. 2016;22:516\u201323. https:\/\/doi.org\/10.1038\/nm.4068","journal-title":"Nat Med"},{"key":"3590_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76109-y","volume":"10","author":"N Jacob","year":"2020","unstructured":"Jacob N, Jaiswal S, Maheshwari D, Nallabelli N, Khatri N, Bhatia A, et al. Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Sci Rep. 2020;10:19120. https:\/\/doi.org\/10.1038\/s41598-020-76109-y","journal-title":"Sci Rep"},{"key":"3590_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Shao J, Liao Y, Wang L, Jia Y, Dong P, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023;14:1186892. https:\/\/doi.org\/10.3389\/fimmu.2023.1186892","journal-title":"Front Immunol"},{"key":"3590_CR127","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1523\/JNEUROSCI.1359-19.2019","volume":"40","author":"R Sadler","year":"2020","unstructured":"Sadler R, Cramer JV, Heindl S, Kostidis S, Betz D, Zuurbier KR, et al. Short-chain fatty acids improve poststroke recovery via immunological mechanisms. J Neurosci. 2020;40:1162\u201373. https:\/\/doi.org\/10.1523\/JNEUROSCI.1359-19.2019","journal-title":"J Neurosci"},{"key":"3590_CR128","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11033-022-08038-0","volume":"50","author":"NM Swer","year":"2023","unstructured":"Swer NM, Venkidesh BS, Murali TS, Mumbrekar KD. Gut microbiota-derived metabolites and their importance in neurological disorders. Mol Biol Rep. 2023;50:1663\u201375. https:\/\/doi.org\/10.1007\/s11033-022-08038-0","journal-title":"Mol Biol Rep"},{"key":"3590_CR129","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/bs.pbr.2023.01.003","volume":"278","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K. Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression. Prog Brain Res. 2023;278:61\u201377. https:\/\/doi.org\/10.1016\/bs.pbr.2023.01.003","journal-title":"Prog Brain Res"},{"key":"3590_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111089","volume":"27","author":"L Xie","year":"2024","unstructured":"Xie L, Zhuang Z, Guo B, Huang Y, Shi X, Huang Z, et al. Ketamine induced gut microbiota dysbiosis and barrier and hippocampal dysfunction in rats. iScience. 2024;27:111089. https:\/\/doi.org\/10.1016\/j.isci.2024.111089","journal-title":"iScience"},{"key":"3590_CR131","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2147\/NDT.S476420","volume":"20","author":"C Li","year":"2024","unstructured":"Li C, Zhu C, Tu G, Chen Z, Mo Z, Luo C. Impact of altered gut microbiota on ketamine-induced conditioned place preference in mice. Neuropsychiatr Dis Treat. 2024;20:1725\u201340. https:\/\/doi.org\/10.2147\/NDT.S476420","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3590_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115137","volume":"165","author":"C Li","year":"2023","unstructured":"Li C, Zhang J, Liu H, Yuan H, Cai J, Foga\u00e7a MV, et al. The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression. Biomed Pharmacother. 2023;165:115137. https:\/\/doi.org\/10.1016\/j.biopha.2023.115137","journal-title":"Biomed Pharmacother"},{"key":"3590_CR133","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.3390\/nu14183766","volume":"14","author":"A Mechli\u0144ska","year":"2022","unstructured":"Mechli\u0144ska A, W\u0142odarczyk A, Grucha\u0142a-Niedoszytko M, Ma\u0142gorzewicz S, Cuba\u0142a WJ. Dietary patterns of treatment-resistant depression patients. Nutrients. 2022;14:3766. https:\/\/doi.org\/10.3390\/nu14183766","journal-title":"Nutrients"},{"key":"3590_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0791-y","volume":"15","author":"FN Jacka","year":"2017","unstructured":"Jacka FN, O\u2019Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the \u2018SMILES\u2019 trial). BMC Med. 2017;15:23. https:\/\/doi.org\/10.1186\/s12916-017-0791-y","journal-title":"BMC Med"},{"key":"3590_CR135","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamapsychiatry.2023.0685","volume":"80","author":"N Amin","year":"2023","unstructured":"Amin N, Liu J, Bonnechere B, MahmoudianDehkordi S, Arnold M, Batra R, et al. Interplay of metabolome and gut microbiome in individuals with major depressive disorder vs control individuals. JAMA Psychiatry. 2023;80:597\u2013609. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.0685","journal-title":"JAMA Psychiatry"},{"key":"3590_CR136","first-page":"554","volume":"31","author":"M Ga\u0142uszko-W\u0119gielnik","year":"2019","unstructured":"Ga\u0142uszko-W\u0119gielnik M, Wiglusz MS, S\u0142upski J, Sza\u0142ach \u0141, W\u0142odarczk A, G\u00f3rska N, et al. Efficacy of ketamine in bipolar depression: focus on anhedonia. Psychiatr Danub. 2019;31:554\u201360.","journal-title":"Psychiatr Danub"},{"key":"3590_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12356","volume":"14","author":"X Song","year":"2024","unstructured":"Song X, Liang J, Lin S, Xie Y, Ke C, Ao D, et al. Gut-lung axis and asthma: a historical review on mechanism and future perspective. Clin Transl Allergy. 2024;14:e12356. https:\/\/doi.org\/10.1002\/clt2.12356","journal-title":"Clin Transl Allergy"},{"key":"3590_CR138","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00203-024-03843-6","volume":"206","author":"C Xu","year":"2024","unstructured":"Xu C, Hao M, Zai X, Song J, Huang Y, Gui S, et al. A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases. Arch Microbiol. 2024;206:107. https:\/\/doi.org\/10.1007\/s00203-024-03843-6","journal-title":"Arch Microbiol"},{"key":"3590_CR139","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/mi.2011.55","volume":"5","author":"S Keely","year":"2012","unstructured":"Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5:7\u201318. https:\/\/doi.org\/10.1038\/mi.2011.55","journal-title":"Mucosal Immunol"},{"key":"3590_CR140","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00408-008-9080-z","volume":"186","author":"A Ekbom","year":"2008","unstructured":"Ekbom A, Brandt L, Granath F, L\u00f6fdahl C, Egesten A. Increased risk of both ulcerative colitis and Crohn\u2019s disease in a population suffering from COPD. Lung. 2008;186:167\u201372. https:\/\/doi.org\/10.1007\/s00408-008-9080-z","journal-title":"Lung"},{"key":"3590_CR141","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1378\/chest.13-0584","volume":"145","author":"EPA Rutten","year":"2014","unstructured":"Rutten EPA, Lenaerts K, Buurman WA, Wouters EFM. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest. 2014;145:245\u201352. https:\/\/doi.org\/10.1378\/chest.13-0584","journal-title":"Chest"},{"key":"3590_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.779620","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Liao Y. Gut-lung crosstalk in sepsis-induced acute lung injury. Front Microbiol. 2021;12:779620. https:\/\/doi.org\/10.3389\/fmicb.2021.779620","journal-title":"Front Microbiol"},{"key":"3590_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.808302","volume":"9","author":"B Liu","year":"2022","unstructured":"Liu B, Yu Y, Zhao M, Xiao K, Yan P, Duan Z, et al. Correlation analysis of the microbiome and immune function in the lung-gut axis of critically ill patients in the ICU. Front Med (Lausanne). 2022;9:808302. https:\/\/doi.org\/10.3389\/fmed.2022.808302","journal-title":"Front Med (Lausanne)"},{"key":"3590_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.241","volume":"3","author":"Y Wang","year":"2024","unstructured":"Wang Y, He F, Liu B, Wu X, Han Z, Wang X, et al. Interaction between intestinal mycobiota and microbiota shapes lung inflammation. iMeta. 2024;3:e241. https:\/\/doi.org\/10.1002\/imt2.241","journal-title":"iMeta"},{"key":"3590_CR145","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/procel\/pwad028","volume":"14","author":"T Wan","year":"2023","unstructured":"Wan T, Wang Y, He K, Zhu S. Microbial sensing in the intestine. Protein Cell. 2023;14:824\u201360. https:\/\/doi.org\/10.1093\/procel\/pwad028","journal-title":"Protein Cell"},{"key":"3590_CR146","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41579-024-01048-8","volume":"22","author":"M \u00d6z\u00e7am","year":"2024","unstructured":"\u00d6z\u00e7am M, Lynch SV. The gut-airway microbiome axis in health and respiratory diseases. Nat Rev Microbiol. 2024;22:492\u2013506. https:\/\/doi.org\/10.1038\/s41579-024-01048-8","journal-title":"Nat Rev Microbiol"},{"key":"3590_CR147","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1164\/rccm.202206-1066TR","volume":"207","author":"L Wang","year":"2023","unstructured":"Wang L, Cai Y, Garssen J, Henricks PAJ, Folkerts G, Braber S. The bidirectional gut-lung axis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2023;207:1145\u201360. https:\/\/doi.org\/10.1164\/rccm.202206-1066TR","journal-title":"Am J Respir Crit Care Med"},{"key":"3590_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30612","volume":"10","author":"Z Song","year":"2024","unstructured":"Song Z, Meng Y, Fricker M, Li X, Tian H, Tan Y, et al. The role of gut-lung axis in COPD: pathogenesis, immune response, and prospective treatment. Heliyon. 2024;10:e30612. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30612","journal-title":"Heliyon"},{"key":"3590_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120885","volume":"307","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Eguchi A, Wei Y, Shinno-Hashimoto H, Fujita Y, Ishima T, et al. Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis. Life Sci. 2022;307:120885. https:\/\/doi.org\/10.1016\/j.lfs.2022.120885","journal-title":"Life Sci"},{"key":"3590_CR150","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-2600(15)00427-0","volume":"4","author":"RP Dickson","year":"2016","unstructured":"Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4:59\u201372. https:\/\/doi.org\/10.1016\/S2213-2600(15)00427-0","journal-title":"Lancet Respir Med"},{"key":"3590_CR151","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1097\/00003246-200007000-00065","volume":"28","author":"P Yu","year":"2000","unstructured":"Yu P, Martin CM. Increased gut permeability and bacterial translocation in Pseudomonas pneumonia-induced sepsis. Crit Care Med. 2000;28:2573\u20137. https:\/\/doi.org\/10.1097\/00003246-200007000-00065","journal-title":"Crit Care Med"},{"key":"3590_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.943791","volume":"13","author":"Y Wu","year":"2022","unstructured":"Wu Y, Li Y, Luo Y, Zhou Y, Wen J, Chen L, et al. Gut microbiome and metabolites: the potential key roles in pulmonary fibrosis. Front Microbiol. 2022;13:943791. https:\/\/doi.org\/10.3389\/fmicb.2022.943791","journal-title":"Front Microbiol"},{"key":"3590_CR153","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e41","volume":"24","author":"HJ Park","year":"2024","unstructured":"Park HJ, Yu D, Hong S, Lee J, Park S, Park MS, et al. Bifidobacterium longum RAPO attenuates dermal and pulmonary fibrosis in a mouse model of systemic sclerosis through macrophage modulation and growth of short-chain fatty acid producers. Immune Netw. 2024;24:e41. https:\/\/doi.org\/10.4110\/in.2024.24.e41","journal-title":"Immune Netw"},{"key":"3590_CR154","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/resp.12815","volume":"21","author":"B Chen","year":"2016","unstructured":"Chen B, Cai H, Xue S, You W, Liu B, Jiang H. Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways. Respirology. 2016;21:1075\u201380. https:\/\/doi.org\/10.1111\/resp.12815","journal-title":"Respirology"},{"key":"3590_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00631-4","volume":"10","author":"J Li","year":"2024","unstructured":"Li J, Wu W, Kong X, Yang X, Li K, Jiang Z, et al. Roles of gut microbiome-associated metabolites in pulmonary fibrosis by integrated analysis. NPJ Biofilms Microbiomes. 2024;10:154. https:\/\/doi.org\/10.1038\/s41522-024-00631-4","journal-title":"NPJ Biofilms Microbiomes"},{"key":"3590_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106321","volume":"182","author":"Z Wang","year":"2022","unstructured":"Wang Z, Liu J, Li F, Luo Y, Ge P, Zhang Y, et al. The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids. Pharmacol Res. 2022;182:106321. https:\/\/doi.org\/10.1016\/j.phrs.2022.106321","journal-title":"Pharmacol Res"},{"key":"3590_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106321","volume":"28","author":"M Ziaka","year":"2024","unstructured":"Ziaka M, Exadaktylos A. Gut-derived immune cells and the gut-lung axis in ARDS. Crit Care. 2024;28:220. https:\/\/doi.org\/10.1016\/j.phrs.2022.106321","journal-title":"Crit Care"},{"key":"3590_CR158","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijbiomac.2022.09.015","volume":"221","author":"C Shi","year":"2022","unstructured":"Shi C, Zhou L, Li H, Shi X, Zhang Y, Lu Y, et al. Intestinal microbiota metabolizing Houttuynia cordata polysaccharides in H1N1 induced pneumonia mice contributed to Th17\/Treg rebalance in gut-lung axis. Int J Biol Macromol. 2022;221:288\u2013302. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.015","journal-title":"Int J Biol Macromol"},{"key":"3590_CR159","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1165\/rcmb.2020-0196TR","volume":"64","author":"Y Ma","year":"2021","unstructured":"Ma Y, Yang X, Chatterjee V, Wu MH, Yuan SY. The gut-lung axis in systemic inflammation. role of mesenteric lymph as a conduit. Am J Respir Cell Mol Biol. 2021;64:19\u201328. https:\/\/doi.org\/10.1165\/rcmb.2020-0196TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3590_CR160","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0b013e3180caa3af","volume":"246","author":"M Senthil","year":"2007","unstructured":"Senthil M, Watkins A, Barlos D, Xu D, Lu Q, Abungu B, et al. Intravenous injection of trauma-hemorrhagic shock mesenteric lymph causes lung injury that is dependent upon activation of the inducible nitric oxide synthase pathway. Ann Surg. 2007;246:822\u201330. https:\/\/doi.org\/10.1097\/SLA.0b013e3180caa3af","journal-title":"Ann Surg"},{"key":"3590_CR161","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1111\/j.1749-6632.2010.05713.x","volume":"1207","author":"EA Deitch","year":"2010","unstructured":"Deitch EA. Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann N Y Acad Sci. 2010;1207:E103\u2013E111. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05713.x","journal-title":"Ann N Y Acad Sci"},{"key":"3590_CR162","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10753-014-0091-z","volume":"38","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhang S, Tsui N. Mesenteric lymph duct drainage attenuates acute lung injury in rats with severe intraperitoneal infection. Inflammation. 2015;38:1239\u201349. https:\/\/doi.org\/10.1007\/s10753-014-0091-z","journal-title":"Inflammation"},{"key":"3590_CR163","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/BF00261496","volume":"15","author":"T Dugernier","year":"1989","unstructured":"Dugernier T, Reynaert MS, Deby-Dupont G, Roeseler JJ, Carlier M, Squifflet JP, et al. Prospective evaluation of thoracic-duct drainage in the treatment of respiratory failure complicating severe acute pancreatitis. Intensive Care Med. 1989;15:372\u20138. https:\/\/doi.org\/10.1007\/BF00261496","journal-title":"Intensive Care Med"},{"key":"3590_CR164","doi-asserted-by":"publisher","first-page":"813","DOI":"10.17219\/acem\/121936","volume":"29","author":"D Xu","year":"2020","unstructured":"Xu D, Sun X, Zhang Y. Cao L. Ketamine alleviates HMGB1-induced acute lung injury through TLR4 signaling pathway. Adv Clin Exp Med. 2020;29:813\u20137. https:\/\/doi.org\/10.17219\/acem\/121936","journal-title":"Adv Clin Exp Med"},{"key":"3590_CR165","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8713701","volume":"2022","author":"J Cao","year":"2022","unstructured":"Cao J, Mai H, Chen Y, Yuan R, Fang E, Liu M, et al. Ketamine promotes LPS-induced pulmonary autophagy and reduces apoptosis through the AMPK\/mTOR pathway. Contrast Media Mol Imaging. 2022;2022:8713701. https:\/\/doi.org\/10.1155\/2022\/8713701","journal-title":"Contrast Media Mol Imaging"},{"key":"3590_CR166","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00228-022-03374-3","volume":"78","author":"L La Via","year":"2022","unstructured":"La Via L, Sanfilippo F, Cuttone G, Dezio V, Falcone M, Brancati S, et al. Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. Eur J Clin Pharmacol. 2022;78:1613\u201322. https:\/\/doi.org\/10.1007\/s00228-022-03374-3","journal-title":"Eur J Clin Pharmacol"},{"key":"3590_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112725","volume":"139","author":"S Cai","year":"2024","unstructured":"Cai S, Liu A, Xie W, Zhang X, Su B, Mao Y, et al. Esketamine mitigates mechanical ventilation-induced lung injury in chronic obstructive pulmonary disease rats via inhibition of the MAPK\/NF-\u03baB signaling pathway and reduction of oxidative stress. Int Immunopharmacol. 2024;139:112725. https:\/\/doi.org\/10.1016\/j.intimp.2024.112725","journal-title":"Int Immunopharmacol"},{"key":"3590_CR168","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40789","volume":"15","author":"AS Binsaeedu","year":"2023","unstructured":"Binsaeedu AS, Prabakar D, Ashkar M, Joseph C, Alsabri M. Evaluating the safety and efficacy of ketamine as a bronchodilator in pediatric patients with acute asthma exacerbation: a review. Cureus. 2023;15:e40789. https:\/\/doi.org\/10.7759\/cureus.40789","journal-title":"Cureus"},{"key":"3590_CR169","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.2147\/DDDT.S391010","volume":"16","author":"S Xiao","year":"2022","unstructured":"Xiao S, Zhou Y, Wang Q, Yang D. Ketamine attenuates airway inflammation via inducing inflammatory cells apoptosis and activating Nrf2 pathway in a mixed-granulocytic murine asthma model. Drug Des Devel Ther. 2022;16:4411\u201328. https:\/\/doi.org\/10.2147\/DDDT.S391010","journal-title":"Drug Des Devel Ther"},{"key":"3590_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113065","volume":"142","author":"J Shi","year":"2024","unstructured":"Shi J, Song S, Wang Y, Wu K, Liang G, Wang A, et al. Esketamine alleviates ferroptosis-mediated acute lung injury by modulating the HIF-1\u03b1\/HO-1 pathway. Int Immunopharmacol. 2024;142:113065. https:\/\/doi.org\/10.1016\/j.intimp.2024.113065","journal-title":"Int Immunopharmacol"},{"key":"3590_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175580","volume":"945","author":"J Saito","year":"2023","unstructured":"Saito J, Zao H, Wu L, Iwasaki M, Sun Q, Hu C, et al. \u201cAnti-cancer\u201d effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells. Eur J Pharmacol. 2023;945:175580. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175580","journal-title":"Eur J Pharmacol"},{"key":"3590_CR172","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07779-y","volume":"25","author":"D Zhang","year":"2024","unstructured":"Zhang D, Liang Y, Bao D, Xiong W, Li L, Wang Y, et al. Effects of small-dose S-ketamine on anesthesia-induced atelectasis in patients undergoing general anesthesia accessed by lung ultrasound: study protocol for a randomized, double-blinded controlled trial. Trials. 2024;25:64. https:\/\/doi.org\/10.1186\/s13063-023-07779-y","journal-title":"Trials"},{"key":"3590_CR173","doi-asserted-by":"publisher","first-page":"e112622","DOI":"10.1371\/journal.pone.0112622","volume":"9","author":"C Fastner","year":"2014","unstructured":"Fastner C, Mairb\u00e4url H, Weber NC, van der Sluijs K, Hackl F, Hotz L, et al. Intravenous S-ketamine does not inhibit alveolar fluid clearance in a septic rat model. PloS one. 2014;9:e112622. https:\/\/doi.org\/10.1371\/journal.pone.0112622","journal-title":"PloS one"},{"key":"3590_CR174","doi-asserted-by":"publisher","first-page":"25m15789","DOI":"10.4088\/JCP.25m15789","volume":"86","author":"R Meisner","year":"2025","unstructured":"Meisner R, Li S, Boyle B, Valdivia V, Sedgewick A, Dai D, et al. Comparative effects of repeated ketamine infusion versus intranasal esketamine in patients with treatment-resistant depression: a retrospective chart review. J Clin Psychiatry. 2025;86:25m15789. https:\/\/doi.org\/10.4088\/JCP.25m15789","journal-title":"J Clin Psychiatry"},{"key":"3590_CR175","doi-asserted-by":"publisher","first-page":"25lr16166","DOI":"10.4088\/JCP.25lr16166","volume":"87","author":"Y Tan","year":"2025","unstructured":"Tan Y, Hashimoto K. Racemic ketamine vs esketamine in treatment-resistant depression: the overlooked role of arketamine. J Clin Psychiatry. 2025;87:25lr16166. https:\/\/doi.org\/10.4088\/JCP.25lr16166","journal-title":"J Clin Psychiatry"},{"key":"3590_CR176","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00406-024-01770-7","volume":"275","author":"K Hashimoto","year":"2025","unstructured":"Hashimoto K. Are \u201cmystical experiences\u201d essential for antidepressant actions of ketamine and the classic psychedelics? Eur Arch Psychiatry Clin Neurosci. 2025;275:1333\u201346. https:\/\/doi.org\/10.1007\/s00406-024-01770-7","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3590_CR177","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00406-023-01732-5","volume":"275","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Du Z, Shen Y, Zhou Q, Zhu H. The correlation of esketamine with specific adverse events: a deep drive into the FAERS database. Eur Arch Psychiatry Clin Neurosci. 2025;275:1373\u201381. https:\/\/doi.org\/10.1007\/s00406-023-01732-5","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3590_CR178","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40360-025-00992-2","volume":"26","author":"B Deng","year":"2025","unstructured":"Deng B, Fu Z, Li L, Xu Y, Yang Z, Zhai X, et al. The post-marketing safety of Esketamine among older adults (\u2265 65): an real-world pharmacovigilance study. BMC Pharmacol Toxicol. 2025;26:154. https:\/\/doi.org\/10.1186\/s40360-025-00992-2","journal-title":"BMC Pharmacol Toxicol"},{"key":"3590_CR179","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00228-025-03954-z","volume":"82","author":"C Pisanu","year":"2025","unstructured":"Pisanu C, Imai S, Tsuchiya M, Inoue M, Ikegami K, Zammarchi G, et al. A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals. Eur J Clin Pharmacol. 2025;82:13. https:\/\/doi.org\/10.1007\/s00228-025-03954-z","journal-title":"Eur J Clin Pharmacol"},{"key":"3590_CR180","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1176\/appi.ajp.20240655","volume":"182","author":"G Sanacora","year":"2025","unstructured":"Sanacora G, Ahmed M, Brown B, Cabrera P, Doherty T, Himedan M, et al. Real-world safety of esketamine nasal spray: a comprehensive analysis almost 5 years after first approval. Am J Psychiatry. 2025;182:913\u201321. https:\/\/doi.org\/10.1176\/appi.ajp.20240655","journal-title":"Am J Psychiatry"},{"key":"3590_CR181","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1176\/appi.ajp.20240515","volume":"182","author":"KN Fountoulakis","year":"2025","unstructured":"Fountoulakis KN, Saitis A, Schatzberg AF. Esketamine treatment for depression in adults: a PRISMA systematic review and meta-analysis. Am J Psychiatry. 2025;182:259\u201375. https:\/\/doi.org\/10.1176\/appi.ajp.20240515","journal-title":"Am J Psychiatry"},{"key":"3590_CR182","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1176\/appi.ajp.20250745","volume":"182","author":"AF Schatzberg","year":"2025","unstructured":"Schatzberg AF, Fountoulakis KN. Esketamine 5 years after approval: welcome new data with continuing questions. Am J Psychiatry. 2025;182:892\u20133. https:\/\/doi.org\/10.1176\/appi.ajp.20250745","journal-title":"Am J Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03590-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03590-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03590-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:12:08Z","timestamp":1785939128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03590-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":182,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3590"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03590-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Hashimoto is one of the editorial board members of this journal. Dr. Hashimoto is the inventor of filed patent applications on \u201cThe use of (R)-ketamine in the treatment of psychiatric diseases\u201d, \u201c(S)-norketamine and salt thereof as pharmaceutical\u201d, \u201c(R)-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder\u201d, \u201cPreventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases\u201d, and \u201c(R)-ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder\u201d by the Chiba University. Dr. Hashimoto also declares that he has received research support from Otsuka (Japan). Other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}